- 作者：Moses Lee ; Hyung-Keun Song ; Kyu-Hyun Yang ; kyang@yuhs.ac ; kyang@yumc.yonsei.ac.kr
- 关键词：Cancellous bone graft ; Tibia ; Intramedullary nail
- 刊名：Injury
- 出版年：2012
- 期刊代码：120_00201383
- 类别：med
- 出版时间：July, 2012
- 卷：43
- 期：7
- 页码：1118-1123
- 文件大小：914 K
Background
The purpose of this study is to introduce and review the clinical outcomes of a new technique for harvesting autogenous cancellous bone grafts in association with tibial intramedullary (IM) nailing.Materials and methods
We retrospectively reviewed 21 patients who received autogenous cancellous bone grafts obtained from the entry portal of a tibial IM nail for fracture gaps, malalignment or nonunion in the lower extremities. All patients were scheduled to receive IM nailing or had already received IM nailing for the fixation of an ipsilateral tibia shaft fracture. A total of 33 patients who received only tibial IM nailing were selected as a control group. Through the follow-up, postoperative complications related to the bone harvest were monitored. Further by taking serial X-rays, radiographic changes of the donor site and the knee joint were closely observed. Knee pain (visual analogue scale (VAS)) and function (Lysholm knee score) were compared between the study group and the control group.
Results
At the last follow-up, the average VAS in the study group was 1.28 (0-5), which was not significantly different from the control group (VAS: 1.36, range 0-7) (P = 0.985). The range of motion of the knee joint was similar in both groups, averaging 130.23掳 (range: 115-135掳) and 131.36掳 (range: 115-135掳), respectively. There was no significant difference in the Lysholm knee score between the study and control groups (P = 0.610). All patients exhibited complete fracture healing at an average of 6 months and no complications associated with the bone donor site were observed.
Conclusions
By using the new technique, autogenous cancellous bone grafting can be performed conveniently and safely to treat fracture gaps, malalignment or nonunion in the lower extremities without additional morbidity at the donor site.